Eli Lilly raises outlook on bumper sales of diabetes and weight loss drugs

حوالي سنة فى FT

Shares soar as ‘strong performance’ of Mounjaro and Zepbound medicines underpin jump in revenue

ذكر فى هذا الخبر
شارك الخبر على